复星医药(02196.HK)复宏汉霖分拆上市保证配额记录日为9月4日
格隆汇8月21日丨复星医药(02196.HK)及复星国际(00656.HK)联合宣布,有关建议分拆复宏汉霖并于香港联交所主板独立上市事宜,为确定合资格复星医药H股股东及合资格复星国际股东于优先发售复宏汉霖H股的保证配额的记录日为2019年9月4日(星期三)。复星医药及复星国际各自将于2019年9月4日(星期三)暂停办理股份过户登记手续,该日复星医药及复星国际将不会办理股份过户登记。就合资格享有保证配额复星医药及复星国际股份的最后交易日为2019年8月30日(星期五)。
就合资格复星医药H股股东而言:合资格复星医药H股股东于2019年9月4日(星期三即记录日)每持有132股复星医药H股可认购一(1)股复宏汉霖H股。合资格复星医药H股股东对复宏汉霖H股享有的保证配额不可转让,且未缴足配额不会于香港联交所买卖。
就合资格复星国际股东而言:合资格复星国际股东于2019年9月4日(星期三即记录日)每持有2041股复星国际股份可认购1股复宏汉霖H股。合资格复星国股东对复宏汉霖H股享有的保证配额不可转让,且未缴足配额不会于香港联交所买卖。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.